Plasmapheresis in the treatment of hyperthyroidism associated with agranulocytosis: A case report
- 1 January 2004
- journal article
- case report
- Published by Wiley in Journal of Clinical Apheresis
- Vol. 19 (3) , 148-150
Abstract
Plasmapheresis, also known as therapeutic plasma exchange, is used in the treatment of several disorders. Temporary improvement after plasmapheresis in cases with thyrotoxicosis has been reported. A 55‐year‐old woman presented with agranulocytosis induced by propylthiouracil and clinical signs of heart failure. Three sessions of plasmapheresis were performed. We observed an improvement of thyroid hormone levels and clinical findings as well. Plasmapheresis can be an option when drug treatment of thyrotoxicosis fails. J. Clin. Apheresis 19:148–150, 2004.Keywords
This publication has 22 references indexed in Scilit:
- Hyperthyroidism and the Management of Atrial FibrillationThyroid®, 2002
- Management of ThyrotoxicosisSouthern Medical Journal, 2002
- Management of ThyrotoxicosisSouthern Medical Journal, 2002
- Thyroid Hormone and the Cardiovascular SystemNew England Journal of Medicine, 2001
- Activating Thyrotropin Receptor Mutations Are Present in Nonadenomatous Hyperfunctioning Nodules of Toxic or Autonomous Multinodular GoiterThe Journal of Clinical Endocrinology & Metabolism, 2000
- Germline Polymorphism of Codon 727 of Human Thyroid-Stimulating Hormone Receptor Is Associated with Toxic Multinodular GoiterThe Journal of Clinical Endocrinology & Metabolism, 1999
- Low Serum Thyrotropin Concentrations as a Risk Factor for Atrial Fibrillation in Older PersonsNew England Journal of Medicine, 1994
- The Role of Plasmapheresis in Graves' OphthalmopathyExperimental and Clinical Endocrinology & Diabetes, 1991
- Plasmapheresis: An adjunct to medical management of severe hyperthyroidismJournal of Clinical Apheresis, 1986
- Thyrotoxicosis in institutionalized elderly patients with atrial fibrillationArchives of internal medicine (1960), 1984